West Reading, Pa.-based Tower Health is preparing for a leadership transition.
Category: Featured
'Nurse anesthesiologist' title argument arises in Washington
The District of Columbia’s health department is considering allowing certified registered nurse anesthetists to use the title “nurse anesthesiologist.” Organizations representing healthcare professionals have argued for and against the title change.&nb…
What's new with CVS Health
From layoffs to leadership appointments, here are nine updates from CVS Health in the last 60 days:
UnitedHealthcare CEO shot and killed: 7 notes
UnitedHealthcare’s CEO, Brian Thompson, was fatally shot on the morning of Dec. 4 while exiting a hotel in New York City, according to the New York Police Department.
The race to create an oral GLP-1 obesity drug: 4 things to know
The push to develop the first oral GLP-1 receptor drug for obesity is heating up, as three phase 3 drugs race to become the first approved oral treatment for obesity, Global Data reported Dec. 2.
Physicians and peer reviews: 9 things to know
The strong majority of practicing physicians — 79% — have never undergone a peer review, according to Medscape’s 2024 “Seeking Fairness and Real Guidance: Medscape Physicians and Peer Reviews Report 2024,” published Dec. 4.
Wisconsin hospitals partner on pediatric cardiology
Madison, Wis.-based UW Health Kids and Milwaukee-based Children’s Wisconsin are forming a joint venture to expand access to pediatric cardiac care.
CMS partners with 2 companies on sickle cell therapies
CMS has reached agreements with bluebird bio and Vertex Pharmaceuticals for their FDA-approved gene therapies for sickle cell disease — Casgevy and Lyfgenia, respectively.
5 clinical, allied health roles with highest turnover
Hospital staff turnover improved slightly in 2023 but remained a significant challenge for certain clinical roles, according to the American Hospital Association’s 2025 Environmental Scan report released Dec. 3.
Older adults say stopping CRC screenings after 75 'unacceptable'
While a majority of older adults agree that guidelines limiting colorectal cancer screenings after 75 are acceptable, a strong minority disagreed, according to a recent cross-sectional study conducted by the University of Michigan in Ann Arbor and repo…
